Literature DB >> 22088781

Predictors of intensive care unit admission after total joint arthroplasty.

Hossam AbdelSalam1, Camilo Restrepo, T David Tarity, William Sangster, Javad Parvizi.   

Abstract

Total joint arthroplasty (TJA) is a relatively safe orthopedic procedure. However, complications do occur, and some may necessitate admission to the intensive care unit (ICU). Our purpose was to determine risk factors associated with admittance to ICU after TJA. We evaluated 22,343 primary and revision total hip and knee arthroplasties from 1999 to 2008. One hundred thirty patients were admitted to the ICU. Cases were matched 1:2 for date of surgery, surgeon, and type of surgery. The causes for admission to ICU were recorded. Independent risk factors for ICU admission were smoking, cemented arthroplasty, general anesthesia, allogenic transfusion, higher C-reactive protein, lower hemoglobin level, higher body mass index, and older age. Proper identification and management of these "at-risk" patients may decrease the incidence of ICU admittance after TJA.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22088781     DOI: 10.1016/j.arth.2011.09.027

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  17 in total

1.  Preoperative and surgical factors associated with postoperative intensive care unit admission following operative treatment for degenerative lumbar spine disease.

Authors:  Harrison F Kay; Silky Chotai; Joseph B Wick; David P Stonko; Matthew J McGirt; Clinton J Devin
Journal:  Eur Spine J       Date:  2015-08-27       Impact factor: 3.134

Review 2.  Current Approaches in Hip and Knee Arthroplasty Anaesthesia.

Authors:  Gülen Güler; Şebnem Atıcı; Ercan Kurt; Saffet Karaca; Aysun Yılmazlar
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-02-16

3.  Editorial: Sparse-data Bias-What the Savvy Reader Needs to Know.

Authors:  Seth S Leopold; Raphaël Porcher
Journal:  Clin Orthop Relat Res       Date:  2018-04       Impact factor: 4.176

4.  Smoking may be a harbinger of early failure with ultraporous metal acetabular reconstruction.

Authors:  Adolph V Lombardi; Keith R Berend; Joanne B Adams; Ryan C Jefferson; Michael A Sneller
Journal:  Clin Orthop Relat Res       Date:  2013-02       Impact factor: 4.176

5.  Analysis of related factors of scheduled ICU before primary hip arthroplasty.

Authors:  Jianguang Sun; Yali Yang; Guilan Feng; Chuanxing Liang; Weiming Ling; Hongxin Liao
Journal:  BMC Anesthesiol       Date:  2022-07-13       Impact factor: 2.376

6.  Total hip arthroplasty complications in patients with or without controlled diabetes mellitus during hospitalization.

Authors:  Fernanda Rezende Campos Falcão; Bruno Anderson Gomes Dias; Liz Araujo Wolfovitch; David Sadigursky
Journal:  Rev Bras Ortop       Date:  2016-08-31

7.  Effect of carbazochrome sodium sulfonate combined with tranexamic acid on blood loss and inflammatory response in patients undergoing total hip arthroplasty.

Authors:  Yue Luo; Xin Zhao; Zhouyuan Yang; Releken Yeersheng; Pengde Kang
Journal:  Bone Joint Res       Date:  2021-06       Impact factor: 5.853

8.  Epidemiology of total hip and knee replacement: a cross-sectional study.

Authors:  Mario Lenza; Silvia de Barros Ferraz; Dan Carai Maia Viola; Reynaldo Jesus Garcia Filho; Miguel Cendoroglo Neto; Mario Ferretti
Journal:  Einstein (Sao Paulo)       Date:  2013 Apr-Jun

9.  Risk factors associated with outcomes of hip fracture surgery in elderly patients.

Authors:  Byung Hoon Kim; Sangseok Lee; Byunghoon Yoo; Woo Yong Lee; Yunhee Lim; Mun-Cheol Kim; Jun Heum Yon; Kye-Min Kim
Journal:  Korean J Anesthesiol       Date:  2015-11-25

10.  A population-based survival analysis describing the association of body mass index on time to revision for total hip and knee replacements: results from the UK general practice research database.

Authors:  David Culliford; Joe Maskell; Andy Judge; Nigel K Arden
Journal:  BMJ Open       Date:  2013-11-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.